RA’ANANA, Israel, May 01, 2026 (GLOBE NEWSWIRE) — Inspira Technologies Oxy B.H.N. Ltd. (Nasdaq: IINN, IINNW) (“Inspira” or the “Company”) today announced that it has secured a $596,000 purchase order for an Additively Manufactured Electronics (“AME”) system from a leading Irish technological research university. The order is structured with a non-refundable upfront payment of 40% of the order value, which has been received by the Company, with the balance payable against delivery. The purchasing institution is a leading Irish technological research university recognized for applied research and innovation in information and communications technologies, advanced communications systems, secure digital infrastructure, photonic and quantum networking research, and next-generation industry-facing...

SAN MATEO, Calif., May 01, 2026 (GLOBE NEWSWIRE) — Oportun (Nasdaq: OPRT), a mission-driven financial services company, announced that it has been honored by USA Today as one of America’s Best Customer Service in Financial Services of 2026. Oportun was recognized for the exceptional customer service it provides to members in support of its intelligent borrowing, savings, and budgeting tools. This prestigious award is based on a comprehensive evaluation conducted by USA Today and Plant-A Insights Group, combining feedback from more than 31,000 U.S. consumers with independent research. Customers shared their real experiences with financial service providers, rating what matters most, like professionalism, transparency, and how well companies meet their needs. Only the top 500 best-performing companies earned a place on the final list. “At...

Adtech investor with track record of scaling foundational AI, data infrastructure, and media technologies nominated for Board seat LITTLE ROCK, Ark., May 01, 2026 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV) (the “Company”), a leader in artificial intelligence-driven advertising technology, today announced that Adtech authority Sanja Partalo has been nominated for election to the Company’s Board of Directors at the 2026 annual meeting of shareholders. Partalo is Co-Founder and General Partner of S4S Ventures, where she invests in companies building the foundational technologies reshaping advertising and media. Her influence and impact spans global leadership roles at WPP, where she oversaw strategic partnerships with the world’s largest technology platforms, and a track record of identifying and supporting high-growth companies...

WEST ORANGE, N.J., May 01, 2026 (GLOBE NEWSWIRE) — Bel Fuse Inc. (Nasdaq: BELFA and BELFB), a global designer, manufacturer, and provider of critical electronic components, systems and solutions for customers in aerospace, defense, industrial, and data-driven markets, today announced its investor conference schedule for May 2026:Oppenheimer 21st Annual Industrial Growth ConferenceLynn Hutkin, CFOMark Hodkinson, VP Finance & Corporate ControllerMonday, May 4, 2026Conducting virtual meetings throughout the day with a virtual presentation at 12:00 PM ETKeyBanc Industrials & Basic Materials ConferenceFarouq Tuweiq, CEOLynn Hutkin, CFOWednesday, May 27, 2026InterContinental, BostonConducting meetings throughout the dayCraig-Hallum 23rd Annual Institutional Investor ConferenceFarouq Tuweiq, CEOLynn Hutkin, CFOThursday,...

The addition of Ozempic® pill will give Weight Watchers Med+ members a new FDA-approved oral GLP-1 option for adults living with type 2 diabetes NEW YORK, May 01, 2026 (GLOBE NEWSWIRE) — WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, announced that it will begin offering access to Novo Nordisk’s now available Ozempic® pill (semaglutide) through its Med+ offering and affiliated medical groups. The addition will give members a once-daily GLP-1 option for adults living with type 2 diabetes, further expanding Weight Watchers’ growing portfolio of oral GLP-1 treatments available through a clinically supported program designed to help members succeed. Novo Nordisk first introduced Ozempic® in the U.S. as an injectable GLP-1 for adults with type 2 diabetes, and the brand...

ORLANDO, Fla., May 01, 2026 (GLOBE NEWSWIRE) — Abacus Global Management, Inc. (NYSE: ABX) today announced that Chairman and CEO Jay Jackson will speak at the 2026 Milken Institute Global Conference. He will join the panel “Private Wealth and the Future of Financial Security” on Monday, May 4, 2026, at 10 a.m. PT. The panel will be moderated by Maneet Ahuja of ICONOCLAST and Forbes Media and will include leaders from HSBC Private Bank, Prudential Financial, J.P. Morgan Asset Management and EQT Group. The session can be viewed live at: https://vimeo.com/event/5858036 To request a meeting with Abacus management during the conference, email ir@abacusgm.com. About Abacus Abacus Global Management (NYSE: ABX) is a leading financial services company specializing in alternative asset management, data-driven wealth solutions,...

NEW ALBANY, Ohio, May 01, 2026 (GLOBE NEWSWIRE) — Abercrombie & Fitch Co. (NYSE: ANF) will host its quarterly earnings conference call for all interested parties on Wednesday, May 27, 2026, at 8:30 a.m. ET. A press release detailing the company’s first quarter results is expected to be issued shortly after 7:30 a.m. ET.   In addition, a presentation of the first quarter results will be available on the company’s website at approximately 7:30 a.m. ET.Conference Call: To access the conference call by phone, participants will need to register to obtain a dial-in phone number and an access code. Register for the call using this link.   Webcast: To listen to a live webcast of the call, please visit corporate.abercrombie.com/investors/news-and-events/events/ and click the link to the webcast.   Replay: A replay of...

FLORHAM PARK, N.J., May 01, 2026 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) diseases, today announced its participation in the Digestive Disease Week® (DDW) 2026 annual meeting, being held May 2–5 in Chicago, Illinois. Phathom will engage with the medical and scientific community through a series of activities, including a product theater presentation on VOQUEZNA® (vonoprazan), a first-in-class potassium-competitive acid blocker (PCAB) approved for Gastroesophageal Reflux Disease (GERD), on Monday, May 4 at 12:00 PM CDT, along with a presence on the exhibit floor at booth number 2511. The company will also present clinical and real-world data further characterizing the use of VOQUEZNA across three...